HEXO Corp.
DelistedCIK 1690947fmd_02XVZW885AJC7728M3KCE0RGGHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Aug 01, 2017 to Jul 31, 2022, 5 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total revenues | 5 | 48 | 81 | 124 | 191 |
| Gross profit | 6 | 25 | (58) | 49 | (76) |
| Research and development | – | 3 | 5 | 4 | 3 |
| Selling, general and administrative | 1 | 46 | 53 | 58 | 85 |
| Operating income | (18) | (87) | (477) | (85) | (1,068) |
| Interest expense | 5 | 0 | (10) | 32 | 20 |
| Income before taxes | (23) | (88) | (553) | (115) | (1,112) |
| Income tax expense | – | (18) | (6) | (0) | (39) |
| Net income from continuing operations | – | (70) | (546) | (115) | (1,074) |
| Net income | (23) | (70) | (546) | (115) | (1,074) |